FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322719273> ?p ?o ?g. }

• W4322719273 endingPage "e231070" @default.
• W4322719273 startingPage "e231070" @default.
• W4322719273 abstract "Importance The dilemma between natural rupture risk and adverse outcomes of intervention is of major concern for patients with unruptured arteriovenous malformations (AVMs). The existing risk score for AVM rupture includes factors that are controversial and lacks prospective validation. Objective To develop and robustly validate a reliable scoring system to predict the rupture risk of AVMs. Design, Setting, and Participants This prognostic study developed a prediction model derived from a single-center cohort (derivation cohort) and validated in a multicenter external cohort (multicenter external validation cohort) and a cohort of patients receiving conservative treatment management (conservative treatment validation cohort). Patients were recruited from a nationwide multicenter prospective collaboration registry in China. A total of 4135 patients were enrolled in the registry between August 1, 2011, and September 1, 2021. Of those, 3962 patients were included in the study (3585 in the derivation cohort and 377 in the multicenter external validation cohort); 1028 patients from the derivation cohort who had time-to-event data and prerupture imaging results were included in the conservative treatment validation cohort. Data were analyzed from March 10 to June 21, 2022. Main Outcomes and Measures A scoring system was developed based on risk factors identified from a literature review and a robust selection process. Patients were stratified into different risk groups based on scores to calculate hemorrhage-free probability in future years, and Kaplan-Meier curves were plotted to visualize risk stratification. Receiver operating characteristic curves were used to assess the discrimination of models. Univariable analyses (logistic regression analysis for descriptive data and Cox regression analysis for survival data) were used to compare baseline information and assess bias. Results Among 3962 patients (2311 men [58.3%]; median [IQR] age, 26.1 [14.6-35.5] years), 3585 patients (2100 men [58.6%]; median [IQR] age, 25.9 [14.6-35.0] years) were included in the derivation cohort, and 377 patients (211 men [56.0%]; median [IQR] age, 26.4 [14.5-39.2] years) were included in the multicenter external validation cohort. Thirty-six hemorrhages occurred over a median (IQR) follow-up of 4.2 (0.3-6.0) years among 1028 patients in the conservative treatment validation cohort. Four risk factors were used to develop the scoring system: ventricular system involvement, venous aneurysm, deep location, and exclusively deep drainage (VALE). The VALE scoring system performed well in all 3 cohorts, with areas under the receiver operating characteristic curve of 0.77 (95% CI, 0.75-0.78) in the derivation cohort, 0.85 (95% CI, 0.81-0.89) in the multicenter external validation cohort, and 0.73 (95% CI, 0.65-0.81) in the conservative treatment validation cohort. The 10-year hemorrhage-free rate was 95.5% (95% CI, 87.1%-100%) in the low-risk group, 92.8% (95% CI, 88.8%-97.0%) in the moderate-risk group, and 75.8% (95% CI, 65.1%-88.3%) in the high-risk group; the model discrimination was significant when comparing these rates between the high-risk group and the low- and moderate-risk groups ( P &amp;lt; .001 for both comparisons). Conclusions and Relevance In this prognostic study, the VALE scoring system was developed to distinguish rupture risk among patients with AVMs. The stratification of unruptured AVMs may enable patients with low risk of rupture to avoid unnecessary interventions. These findings suggest that the scoring system is a reliable and applicable tool that can be used to facilitate patient and physician decision-making and reduce unnecessary interventions or unexpected AVM ruptures." @default.
• W4322719273 created "2023-03-03" @default.
• W4322719273 creator A5010929537 @default.
• W4322719273 creator A5018052138 @default.
• W4322719273 creator A5021366604 @default.
• W4322719273 creator A5021537148 @default.
• W4322719273 creator A5023755657 @default.
• W4322719273 creator A5026547866 @default.
• W4322719273 creator A5028705316 @default.
• W4322719273 creator A5030824193 @default.
• W4322719273 creator A5037495489 @default.
• W4322719273 creator A5042470607 @default.
• W4322719273 creator A5042794394 @default.
• W4322719273 creator A5044340711 @default.
• W4322719273 creator A5044666710 @default.
• W4322719273 creator A5045841212 @default.
• W4322719273 creator A5050464467 @default.
• W4322719273 creator A5051460888 @default.
• W4322719273 creator A5051650662 @default.
• W4322719273 creator A5054418300 @default.
• W4322719273 creator A5057838726 @default.
• W4322719273 creator A5058175069 @default.
• W4322719273 creator A5066070885 @default.
• W4322719273 creator A5066344469 @default.
• W4322719273 creator A5071174657 @default.
• W4322719273 creator A5074496995 @default.
• W4322719273 creator A5078414636 @default.
• W4322719273 creator A5082790411 @default.
• W4322719273 creator A5083512745 @default.
• W4322719273 creator A5089294941 @default.
• W4322719273 creator A5090300248 @default.
• W4322719273 date "2023-03-01" @default.
• W4322719273 modified "2023-10-12" @default.
• W4322719273 title "Development and Validation of a Scoring System for Hemorrhage Risk in Brain Arteriovenous Malformations" @default.
• W4322719273 cites W1622706284 @default.
• W4322719273 cites W1965061510 @default.
• W4322719273 cites W1973470461 @default.
• W4322719273 cites W1982437710 @default.
• W4322719273 cites W1994682257 @default.
• W4322719273 cites W2009279657 @default.
• W4322719273 cites W2038259826 @default.
• W4322719273 cites W2048020454 @default.
• W4322719273 cites W2050529289 @default.
• W4322719273 cites W2052619669 @default.
• W4322719273 cites W2063386610 @default.
• W4322719273 cites W2064186732 @default.
• W4322719273 cites W2066788634 @default.
• W4322719273 cites W2070507686 @default.
• W4322719273 cites W2070982129 @default.
• W4322719273 cites W2080492343 @default.
• W4322719273 cites W2081680518 @default.
• W4322719273 cites W2085798012 @default.
• W4322719273 cites W2115273358 @default.
• W4322719273 cites W2130187335 @default.
• W4322719273 cites W2130774572 @default.
• W4322719273 cites W2133114190 @default.
• W4322719273 cites W2142546697 @default.
• W4322719273 cites W2145196535 @default.
• W4322719273 cites W2152641745 @default.
• W4322719273 cites W2154970859 @default.
• W4322719273 cites W2336137879 @default.
• W4322719273 cites W2461117130 @default.
• W4322719273 cites W2463235957 @default.
• W4322719273 cites W2613030232 @default.
• W4322719273 cites W2667816915 @default.
• W4322719273 cites W2751114831 @default.
• W4322719273 cites W2751201418 @default.
• W4322719273 cites W2782176193 @default.
• W4322719273 cites W2964313034 @default.
• W4322719273 cites W3089705688 @default.
• W4322719273 cites W3125392274 @default.
• W4322719273 cites W3157297229 @default.
• W4322719273 cites W3157600800 @default.
• W4322719273 cites W4252054771 @default.
• W4322719273 cites W4376595656 @default.
• W4322719273 doi "https://doi.org/10.1001/jamanetworkopen.2023.1070" @default.
• W4322719273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36857052" @default.
• W4322719273 hasPublicationYear "2023" @default.
• W4322719273 type Work @default.
• W4322719273 citedByCount "6" @default.
• W4322719273 countsByYear W43227192732023 @default.
• W4322719273 crossrefType "journal-article" @default.
• W4322719273 hasAuthorship W4322719273A5010929537 @default.
• W4322719273 hasAuthorship W4322719273A5018052138 @default.
• W4322719273 hasAuthorship W4322719273A5021366604 @default.
• W4322719273 hasAuthorship W4322719273A5021537148 @default.
• W4322719273 hasAuthorship W4322719273A5023755657 @default.
• W4322719273 hasAuthorship W4322719273A5026547866 @default.
• W4322719273 hasAuthorship W4322719273A5028705316 @default.
• W4322719273 hasAuthorship W4322719273A5030824193 @default.
• W4322719273 hasAuthorship W4322719273A5037495489 @default.
• W4322719273 hasAuthorship W4322719273A5042470607 @default.
• W4322719273 hasAuthorship W4322719273A5042794394 @default.
• W4322719273 hasAuthorship W4322719273A5044340711 @default.
• W4322719273 hasAuthorship W4322719273A5044666710 @default.
• W4322719273 hasAuthorship W4322719273A5045841212 @default.
• W4322719273 hasAuthorship W4322719273A5050464467 @default.
• W4322719273 hasAuthorship W4322719273A5051460888 @default.

• next